Providers who continue offering compounded weight loss medications to most or all of their patients after these deadlines are operating outside of FDA guidelines and attempting to exploit regulatory loopholes
Women were then grouped according to whether they received a GLP-1 receptor agonist after their breast cancer diagnosis
Understanding how it compares to alternatives helps you determine if it is the right choice for your specific situation
Every product comes with a Certificate of Analysis

Patients should contact their healthcare provider if they experience any of the following: Seek emergency medical care immediately for: Signs of severe allergic reaction (anaphylaxis), including difficulty breathing, severe rash, or swelling of the face, lips, or throat Severe, persistent abdominal pain that may radiate to your back, with or without vomiting, which could indicate pancreatitis Symptoms of thyroid tumors, such as a lump in the neck, hoarseness, difficulty swallowing, or shortness of breath Contact your provider within 24-48 hours for: Persistent or worsening injection site reactions beyond mild, transient redness New or unusual skin rashes, blistering, or skin changes Signs of gallbladder problems, including upper right abdominal pain, fever, yellowing of skin or eyes, or clay-colored stools Symptoms of kidney problems, such as decreased urination, swelling in legs or feet, or unusual fatigue Recurrent hypoglycemia (blood glucose below 70 mg/dL), especially if taking insulin or sulfonylureas concurrently New or worsening vision changes, particularly if you have a history of diabetic retinopathy Severe, persistent vomiting or diarrhea leading to dehydration If you become pregnant while taking tirzepatide, contact your healthcare provider immediately
